2. Chooi YC, Ding C, Magkos F. The epidemiology of obesity. Metabolism 2019;92:6-10.
6. Bailey KV, Ferro-Luzzi A. Use of body mass index of adults in assessing individual and community nutritional status. Bull World Health Organ 1995;73(5):673-80.
9. Zoccali C, Torino C, Tripepi G, Mallamaci F. Assessment of obesity in chronic kidney disease: what is the best measure? Curr Opin Nephrol Hypertens 2012;21(6):641-6.
16. Sangrós FJ, Torrecilla J, Giráldez-García C, Carrillo L, Mancera J, Mur T, et al. Association of general and abdominal obesity with hypertension, dyslipidemia and prediabetes in the PREDAPS study. Rev Esp Cardiol (Engl Ed) 2018;71(3):170-7.
17. WHO Expert Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 2004;363(9403):157-63.
18. Oh HS. Important significant factors of health-related quality of life (EQ-5D) by age group in Korea based on KNHANES (2014). JKDISS 2017;28(3):573-84.
22. Ritchie SA, Connell JM. The link between abdominal obesity, metabolic syndrome and cardiovascular disease. Nutr Metab Cardiovasc Dis 2007;17(4):319-26.
23. Westphal SA. Obesity, abdominal obesity, and insulin resistance. Clin Cornerstone 2008;9(1):23-9.
24. Pouliot MC, Després JP, Nadeau A, Moorjani S, Prud'Homme D, Lupien PJ, et al. Visceral obesity in men. Associations with glucose tolerance, plasma insulin, and lipoprotein levels. Diabetes 1992;41(7):826-34.
26. Phillips LK, Prins JB. The link between abdominal obesity and the metabolic syndrome. Curr Sci 2008;10(2):156-64.
28. Dalton M, Cameron AJ, Zimmet PZ, Shaw JE, Jolley D, Dunstan DW, et al. Waist circumference, waist-hip ratio and body mass index and their correlation with cardiovascular disease risk factors in Australian adults. J Intern Med 2003;254(6):555-63.